Effects of Growth Hormone in Patients with Chronic Renal Failure: Experience in Children and Adults
Overview
Authors
Affiliations
Recombinant human growth hormone (GH) has proven effective in promoting growth in short children with chronic renal failure before and after renal transplantation. The action of GH and its mediator insulin-like growth factor 1 on body composition, protein, glucose and bone metabolism offers additional therapeutic options. One might be the improvement of the catabolic state in adults with end-stage renal failure. In few pilot studies and two placebo-controlled studies of 6 months duration, GH treatment in adults on dialysis showed clear anabolic effects resulting in a significant increase in lean body mass.
Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury.
Li C, Xia M, Abais J, Liu X, Li N, Boini K Naunyn Schmiedebergs Arch Pharmacol. 2013; 386(6):551-61.
PMID: 23529346 PMC: 3654058. DOI: 10.1007/s00210-013-0848-1.
A review of guidelines for use of growth hormone in pediatric and transition patients.
Cook D, Rose S Pituitary. 2012; 15(3):301-10.
PMID: 22271255 DOI: 10.1007/s11102-011-0372-6.
Gene therapy by electroporation for the treatment of chronic renal failure in companion animals.
Brown P, Bodles-Brakhop A, Pope M, Draghia-Akli R BMC Biotechnol. 2009; 9:4.
PMID: 19149896 PMC: 2663557. DOI: 10.1186/1472-6750-9-4.
The growth hormone-insulin-like growth factor-I axis in chronic kidney disease.
Mak R, Cheung W, Roberts Jr C Growth Horm IGF Res. 2007; 18(1):17-25.
PMID: 17826224 PMC: 2706146. DOI: 10.1016/j.ghir.2007.07.009.
Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling.
Rabkin R, Sun D, Chen Y, Tan J, Schaefer F Pediatr Nephrol. 2005; 20(3):313-8.
PMID: 15692835 DOI: 10.1007/s00467-004-1713-8.